Showing 28 RESULTS FOR
Brain disorder research
In the News: Chicago Sun-Times Covers Lundbeck’s Commitment to Alzheimer’s Research and New Alzheimer’s Treatments
Lundbeck's Doug Williamson, MD, is featured in a Chicago Sun-Times article about Alzheimer's disease research and new approaches to Alzheimer's treatments.
Report Offers Hope, Outlines 537 New Drugs in Development for Neurological Disorders
A new report shows there are 537 medicines in development for neurological disorders, such as Parkinson's disease and Alzheimer's disease. Learn how Lundbeck is advancing treatments for brain disorders.
Inside the Alzheimer's Pipeline: Diversity of Treatments Spells Promise
By Gary Tong, MD, PhD
A new report shows there are 92 medicines in development for Alzheimer’s. Learn what’s different about today’s pipeline.
Video: No Stone Unturned in Mental Health Research
By Doug Williamson, MD
In this video, Dr. Doug Williamson, Lundbeck's Chief Medical Officer and VP of US Medical, discusses putting patients at the center of drug R&D and how Lundbeck is leaving no stone unturned in pursuit of new treatment options.